SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-049621
Filing Date
2022-04-25
Accepted
2022-04-25 16:06:23
Documents
4
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2212652-1_def14a.htm DEF 14A 433153
2 GRAPHIC sg_davidpluci-bw.jpg GRAPHIC 19965
3 GRAPHIC tm2212652d1-pxy_proxy1bw.jpg GRAPHIC 713462
4 GRAPHIC tm2212652d1-pxy_proxy2bw.jpg GRAPHIC 714966
  Complete submission text file 0001104659-22-049621.txt   2425406
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40536 | Film No.: 22849740
SIC: 2834 Pharmaceutical Preparations